Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing
Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing
复制标题
通过全基因组测序对中国多发性内分泌肿瘤2A型家系进行基因诊断
DOI:
10.1007/s12038-017-9686-5
复制
发表时间:
2017-06-01
影响因子:
2.9
通讯作者:
Qi, Xiao-Ping
中科院分区:
文献类型:
--
作者:
Du, Zhen-Fang;Li, Peng-Fei;Qi, Xiao-Ping
Approximately 98% of patients with multiple endocrine neoplasia type 2A (MEN 2A) have an identifiableRETmutation. Prophylactic or early total thyroidectomy or pheochromocytoma/parathyroid removal in patients can be preventative or curative and has become standard management. The general strategy forRETscreening on family members at risk is to sequence the most commonly affected exons and, if negative, to extend sequencing to additional exons. However, different families with MEN 2A due to the sameRETmutation often have significant variability in the clinical exhibition of disease and aggressiveness of the MTC, which implies additional genetic loci exsit beyondRETcoding region. Whole genome sequencing (WGS) greatly expands the breadth of screening from genes associated with a particular disease to the whole genome and, potentially, all the information that the genome contains about diseases or traits. This is presumably due to additive effect of disease modifying factors. In this study, we performed WGS on a typical Chinese MEN 2A proband and identified the pathogenicRETp.C634R mutation. We also identified several neutral variants withinRETand pheochromocytoma-related genes. Moreover, we found several interesting structural variants including genetic deletions (RSPO1,OVCH2andAP3S1, etc.) and fusion transcripts (FSIP1-BAZ2A, etc.).